Spots Global Cancer Trial Database for The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"

Official Title: Long Term Outcomes in Critically Ill Haematological Patients. The Use of Intensive Care in Critically Ill Cancer Haematological Patients

Study ID: NCT01172132

Conditions

Hematological Malignancies

Interventions

Study Description

Brief Summary: The purpose of this study is to determine: * Condition of intensive care unit (ICU) admission in patients with haematological malignancies. * ICU hospital and up to one year mortality. * Assessment of post ICU burden and health related quality at 90-d and 1 year.

Detailed Description: 1. To identify prognostic factors of short and medium term mortality, by underlining the respective weights of organ dysfunction and characteristics of underlined malignancy 2. Evaluate the health related quality of life of intensive care survivors(SF36) 3. Impact of intensive care on families burden (HADS, IES). 4. Assess clinicians' satisfaction ( intensivists, haematologists and intensive care nurses) in relation to medical decision-making. 5. Establish the relevance of antifungal treatments.